Search results for "genetic engineering"

showing 10 items of 54 documents

Protein delivery by subviral particles of human cytomegalovirus

2003

Direct protein delivery is an emerging technology in vaccine development and gene therapy. We could previously show that subviral dense bodies (DB) of human cytomegalovirus (HCMV), a beta-herpesvirus, transport viral proteins into target cells by membrane fusion. Thus these non-infectious particles provide a candidate delivery system for the prophylactic and therapeutic application of proteins. Here we provide proof of principle that DB can be modified genetically. A 55 kDa fusion protein consisting of the green fluorescent protein and the neomycin phosphotransferase could be packed in and delivered into cells by recombinant DB in a functional fashion. Furthermore, transfer of protein into …

Human cytomegalovirusRecombinant Fusion ProteinsGenetic enhancementGenetic VectorsGreen Fluorescent ProteinsCongenital cytomegalovirus infectionCytomegalovirusGene ExpressionBiologylaw.inventionGreen fluorescent proteinlawVaccines DNAGeneticsmedicineHumansMolecular BiologyKanamycin KinaseSecretory VesiclesLipid bilayer fusionDendritic CellsGenetic TherapyFibroblastsmedicine.diseaseFusion proteinVirologyCell biologyLuminescent ProteinsFluorescent Antibody Technique DirectRecombinant DNAMolecular MedicineDelivery systemGenetic EngineeringGene Therapy
researchProduct

Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins

2001

The ability to couple genotype to phenotype has proven to be of immense value in systems such as phage display and has allowed genes encoding novel functions to be selected directly from complex libraries. However, the complexity of many eukaryotic proteins places a severe constraint on successful display in Escherichia coli. This restriction could be resolved if a eukaryotic virus could be similarly engineered for display purposes. Preliminary data have suggested that the baculovirus Autographa californica, a multiple nuclear polyhedrosis virus (AcMNPV) is a candidate for eukaryotic virus display because the insertion of peptides into the native virus coat protein, or the expression of for…

InsectaPhage displayExpression vectorbiologyvirusesGene Transfer TechniquesVirionBioengineeringGenome ViralComputational biologybiology.organism_classificationVirologyFusion proteinVirusAutographa californicaPeptide LibraryAnimalsCloning MolecularGenetic EngineeringPeptide libraryBaculoviridaeViral Fusion ProteinsGeneFunctional genomicsBiotechnologyTrends in Biotechnology
researchProduct

Biochemical and Immunological implications of Lutein and Zeaxanthin

2021

Throughout history, nature has been acknowledged for being a primordial source of various bioactive molecules in which human macular carotenoids are gaining significant attention. Among 750 natural carotenoids, lutein, zeaxanthin and their oxidative metabolites are selectively accumulated in the macular region of living beings. Due to their vast applications in food, feed, pharmaceutical and nutraceuticals industries, the global market of lutein and zeaxanthin is continuously expanding but chemical synthesis, extraction and purification of these compounds from their natural repertoire e.g., plants, is somewhat costly and technically challenging. In this regard microbial as well as microalga…

LuteinOxidative degradationQH301-705.5Drug CompoundingBioactive moleculesReviewBiologyCatalysisInorganic ChemistryBiological Factorschemistry.chemical_compoundNutraceuticalDrug StabilityZeaxanthinsHumansMacula LuteaFood scienceBiology (General)Physical and Theoretical Chemistrymacular carotenoidsCRISPR/Cas9QD1-999Molecular BiologyCarotenoidSpectroscopyGene Editingchemistry.chemical_classificationgenetic engineeringEsterificationLuteinOrganic Chemistryfood and beveragesGeneral MedicineResearch needseye diseasesComputer Science ApplicationsZeaxanthinChemistryantioxidantschemistryXanthophyllbioavailabilitylutein binding proteinInternational Journal of Molecular Sciences
researchProduct

Revised annual post-market environmental monitoring (PMEM) report on the cultivation of genetically modified maize MON 810 in 2013 from Monsanto Euro…

2015

Question number: EFSA-Q-2015-00432On request from: European Commission; Following a request from the European Commission, the Panel on Genetically Modified Organisms of the European Food Safety Authority (EFSA GMO Panel) assessed the results of the general surveillance activities contained in the revised annual post-market environmental monitoring (PMEM) report for the 2013 growing season of maize MON 810 provided by Monsanto Europe S.A. The supplied data do not indicate any unanticipated adverse effects on human and animal health or the environment arising from the cultivation of maize MON 810 cultivation in 2013. Similar methodological shortcomings to those observed in previous annual PME…

MON 810literature review[SDV]Life Sciences [q-bio]Veterinary (miscellaneous)reviewTP1-1185Plant Sciencegenetically engineered organismmaizeenvironmental impactZea maysMicrobiologyAgricultural scienceadverse effectEnvironmental monitoringTX341-641Cry1Abliterature searchestransgenic plant2. Zero hungergenetic engineeringGenetically modified maizeanimal healthNutrition. Foods and food supplyeffectChemical technologyquestionnairescreeningtransgenicsliteraturegeneral surveillancerisk assessmenthealthmethodology10079 Institute of Veterinary Pharmacology and Toxicologyfarmer questionnairestechniqueadverse effects; animal health; cultivation; effects; environmental impact; food safety; genetic engineering; genetically engineered organisms; guidelines; health; impact; literature; literature reviews; maize; methodology; monitoring; questionnaires; reviews; risk assessment; screening; techniques; transgenic plants; transgenicsfood safetymonitoringSettore AGR/11 - Entomologia Generale E ApplicataGeographycultivationimpact570 Life sciences; biologyAnimal Science and ZoologyParasitologyguidelineFood Science
researchProduct

Complete tumor prevention by engineered tumor cell vaccines employing nonviral vectors.

2004

We report that 100% mice survival after tumor challenge is achieved with cytokine-engineered cells employing nonviral lipoplexes and without using viral vectors. We describe this effect with cytokine-secreting tumor cell vaccines, based on cell clones or fresh transfected cells. Tumor cells were transfected with murine granulocyte-macrophage colony-stimulating factor (GM-CSF) or IL-4 plasmids employing the cationic lipid DOTAP, were irradiated (150 Gy) and kept frozen until use. The transfection efficacy was analyzed by qRT-PCR and flow cytometry. Vaccination induced potent antitumor rejection, resulting in 100% mice survival. Furthermore, the antitumor immunity was long lasting, since a tw…

MaleCancer ResearchSkin NeoplasmsGenetic enhancementCellGenetic VectorsAntineoplastic AgentsBiologyCancer VaccinesViral vectorFlow cytometryMicemedicineAnimalsMolecular BiologyMelanomaInterleukin 4medicine.diagnostic_testReverse Transcriptase Polymerase Chain ReactionMelanomaGranulocyte-Macrophage Colony-Stimulating FactorTransfectionGenetic TherapyNeoplasms Experimentalmedicine.diseaseFlow CytometryVirologySurvival AnalysisMice Inbred C57BLmedicine.anatomical_structureGranulocyte macrophage colony-stimulating factorMolecular MedicineFemaleInterleukin-4Genetic Engineeringmedicine.drugCancer gene therapy
researchProduct

Aspartoacylase-lacZ knockin mice: an engineered model of Canavan disease.

2011

Canavan Disease (CD) is a recessive leukodystrophy caused by loss of function mutations in the gene encoding aspartoacylase (ASPA), an oligodendrocyte-enriched enzyme that hydrolyses N-acetylaspartate (NAA) to acetate and aspartate. The neurological phenotypes of different rodent models of CD vary considerably. Here we report on a novel targeted aspa mouse mutant expressing the bacterial β-Galactosidase (lacZ) gene under the control of the aspa regulatory elements. X-Gal staining in known ASPA expression domains confirms the integrity of the modified locus in heterozygous aspa lacZ-knockin (aspa(lacZ/+)) mice. In addition, abundant ASPA expression was detected in Schwann cells. Homozygous (…

MaleCentral Nervous SystemCerebellumPathologyAnatomy and PhysiologyCanavan DiseaseMouseMutantlcsh:MedicineNeural HomeostasisBiochemistryMiceNeurobiology of Disease and Regenerationlcsh:ScienceSex CharacteristicsMultidisciplinaryNeuromodulationNeurochemistryGenomicsAnimal ModelsFunctional Genomicsmedicine.anatomical_structureLac OperonNeurologyHomeostatic MechanismsMedicineFemaleNeurochemicalsGenetic EngineeringResearch ArticleNervous System PhysiologyBiotechnologymedicine.medical_specialtyTransgeneCentral nervous systemNeurophysiologyMice TransgenicNeuroimagingBiologyNeurological SystemAmidohydrolasesWhite matterModel OrganismsGeneticsmedicineAnimalsBiologyNeuropeptidesLeukodystrophylcsh:RComputational Biologymedicine.diseaseMolecular biologyCanavan diseaseAspartoacylaseDisease Models AnimalMetabolismnervous systemSmall MoleculesCellular NeuroscienceMetabolic DisordersMutationGenetics of DiseaseNervous System Componentslcsh:QGene FunctionMolecular NeuroscienceAnimal GeneticsNeurosciencePLoS ONE
researchProduct

Genetically engineered V79 chinese hamster cell expression of purified cytochromeP-450iib1 monooxygenase activity

1989

Chinese hamster V79 fibroblasts, frequently used as target cells in short-term tests for mutagenicity, do not possess measurable monooxygenase activity; in particular, enzymatic oxidation of testosterone (T) cannot be demonstrated. If these V79 cells, however, had been transfected with the cDNA-encoding rat liver cytochrome P-450IIB1 under control of the SV40 early promoter, they stably expressed monooxygenase activity. These so-called SD1 cells then oxidatively metabolized T at a rate of 27 pmol/mg protein/min, converting it to 16 alpha- and 16 beta-hydroxy-T as well as 4-androsten-3,17-dione as sole metabolites in a ratio of 1.1:1.0:1.6. The regio- and stereoselective conversion of T by S…

MaleOxygenaseCytochromeCellTransfectionToxicologyIsozymeChinese hamsterCricetulusCytochrome P-450 Enzyme SystemCricetinaemedicineAnimalsTestosteroneCells CulturedChromatography High Pressure Liquidchemistry.chemical_classificationbiologyRats Inbred StrainsTransfectionKetosteroidsbiology.organism_classificationMolecular biologyRatsIsoenzymesmedicine.anatomical_structureEnzymeBiochemistrychemistryPhenobarbitalMicrosomes LiverOxygenasesbiology.proteinCricetulusGenetic EngineeringOxidation-ReductionJournal of Biochemical Toxicology
researchProduct

Transmissible gastroenteritis virus (TGEV)-based vectors with engineered murine tropism express the rotavirus VP7 protein and immunize mice against r…

2011

A coronavirus vector based on the genome of the porcine transmissible gastroenteritis virus (TGEV) expressing the rotavirus VP7 protein was constructed to immunize and protect against rotavirus infections in a murine model. The tropism of this TGEV-derived vector was modified by replacing the spike S protein with the homologous protein from mouse hepatitis virus (MHV). The rotavirus gene encoding the VP7 protein was cloned into the coronavirus cDNA. BALB/c and STAT1-deficient mice were inoculated with the recombinant viral vector rTGEVS-MHV-VP7, which replicates in the intestine and spreads to other organs such as liver, spleen and lungs. TGEV-specific antibodies were detected in all the in…

MaleViral vectorsRotavirusSwinevirusesRecombinant virusmedicine.disease_causeAntibodies ViralVirus ReplicationMice0302 clinical medicinefluids and secretionsRotavirusAntigens ViralCoronavirus0303 health sciencesMice Inbred BALB CProtectionvirus diseases3. Good healthAnimals SucklingSTAT1 Transcription FactorRNA ViralFemaleGenetic EngineeringGene Expression Regulation ViralDiarrheaBiologyTropismArticleRotavirus InfectionsMicrobiologyViral vectorCell Line03 medical and health sciencesMouse hepatitis virusVirologymedicineAnimalsTropism030304 developmental biologyTransmissible gastroenteritis virusRotavirus Vaccinesbiology.organism_classificationVirologyImmunizationViral replicationCapsid ProteinsImmunity Maternally-Acquired030215 immunology
researchProduct

Isoprenoid biosynthesis in eukaryotic phototrophs: a spotlight on algae.

2011

Isoprenoids are one of the largest groups of natural compounds and have a variety of important functions in the primary metabolism of land plants and algae. In recent years, our understanding of the numerous facets of isoprenoid metabolism in land plants has been rapidly increasing, while knowledge on the metabolic network of isoprenoids in algae still lags behind. Here, current views on the biochemistry and genetics of the core isoprenoid metabolism in land plants and in the major algal phyla are compared and some of the most pressing open questions are highlighted. Based on the different evolutionary histories of the various groups of eukaryotic phototrophs, we discuss the distribution an…

Metabolic networkMevalonic AcidPlant ScienceAlgaePhylogeneticsBotanyGeneticsPlastidPhylogenyPlant ProteinsPhototrophbiologyPhylumTerpenesorganic chemicalsStreptophytafungifood and beveragesGeneral Medicinebiology.organism_classificationDimethylallyltranstransferaseBiological EvolutionErythritollipids (amino acids peptides and proteins)Green algaeSugar PhosphatesGenetic EngineeringStreptophytaAgronomy and Crop ScienceMetabolic Networks and PathwaysPlant science : an international journal of experimental plant biology
researchProduct

Glial Promoter Selectivity following AAV-Delivery to the Immature Brain

2013

Recombinant adeno-associated virus (AAV) vectors are versatile tools for gene transfer to the central nervous system (CNS) and proof-of-concept studies in adult rodents have shown that the use of cell type-specific promoters is sufficient to target AAV-mediated transgene expression to glia. However, neurological disorders caused by glial pathology usually have an early onset. Therefore, modelling and treatment of these conditions require expanding the concept of targeted glial transgene expression by promoter selectivity for gene delivery to the immature CNS. Here, we have investigated the AAV-mediated green fluorescent protein (GFP) expression driven by the myelin basic protein (MBP) or gl…

MouseCanavan DiseaseGene ExpressionDevelopmental and Pediatric NeurologyPediatricsGreen fluorescent protein0302 clinical medicineGene expressionNeurobiology of Disease and RegenerationTransgenesPromoter Regions GeneticCells Cultured0303 health sciencesMultidisciplinaryGlial fibrillary acidic proteinQStatisticsRAge FactorsBrainGenomicsGene TherapyAnimal ModelsDependovirusOligodendrogliamedicine.anatomical_structureNeurologyOrgan SpecificityMedicineGenetic EngineeringResearch ArticleBiotechnologyScienceTransgeneCentral nervous systemGenetic VectorsGreen Fluorescent ProteinsGene deliveryBiologyBiostatistics03 medical and health sciencesModel OrganismsGenomic MedicineDevelopmental NeuroscienceNeuroglial DevelopmentGlial Fibrillary Acidic ProteinmedicineGeneticsAnimalsBiology030304 developmental biologyClinical GeneticsMyelin Basic ProteinGenetic TherapyMolecular biologyOligodendrocyteMyelin basic proteinMice Inbred C57BLAnimals NewbornAstrocytesbiology.protein030217 neurology & neurosurgeryMathematicsTransgenicsNeurosciencePLoS ONE
researchProduct